124 related articles for article (PubMed ID: 21348464)
21. Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes.
Yang F; Wang K; Zhou K; Dai B; Dai J; Liang Y; Cui M
Eur J Med Chem; 2019 Sep; 177():291-301. PubMed ID: 31158745
[TBL] [Abstract][Full Text] [Related]
22. Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties.
Maes V; Garcia-Garayoa E; Bläuenstein P; Tourwé D
J Med Chem; 2006 Mar; 49(5):1833-6. PubMed ID: 16509599
[TBL] [Abstract][Full Text] [Related]
23. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel technetium-99m labeled phenylbenzoxazole derivatives as potential imaging probes for β-amyloid plaques in brain.
Wang X; Cui M; Yu P; Li Z; Yang Y; Jia H; Liu B
Bioorg Med Chem Lett; 2012 Jul; 22(13):4327-31. PubMed ID: 22652052
[TBL] [Abstract][Full Text] [Related]
25. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
[TBL] [Abstract][Full Text] [Related]
26. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents.
Kim DW; Kim WH; Kim MH; Kim CG
J Labelled Comp Radiopharm; 2015 Feb; 58(2):30-5. PubMed ID: 25583160
[TBL] [Abstract][Full Text] [Related]
28. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
29. The synthesis of D-trihydroxyllysine-based oligopeptides as a hydrophilic scaffold and its application to the synthesis of bifunctional chelating agents for use as bone tracers.
Tanaka H; Ando Y; Abe T; Takahashi T
Chem Asian J; 2008 Dec; 3(12):2033-45. PubMed ID: 18956475
[TBL] [Abstract][Full Text] [Related]
30. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
Psimadas D; Fani M; Gourni E; Loudos G; Xanthopoulos S; Zikos C; Bouziotis P; Varvarigou AD
Bioorg Med Chem; 2012 Apr; 20(8):2549-57. PubMed ID: 22445386
[TBL] [Abstract][Full Text] [Related]
32. Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
Ke S; Wen X; Wu QP; Wallace S; Charnsangavej C; Stachowiak AM; Stephens CL; Abbruzzese JL; Podoloff DA; Li C
J Nucl Med; 2004 Jan; 45(1):108-15. PubMed ID: 14734682
[TBL] [Abstract][Full Text] [Related]
33. Tc-99m-labeled RGD-conjugated alpha-melanocyte stimulating hormone hybrid peptides with reduced renal uptake.
Yang J; Hu CA; Miao Y
Amino Acids; 2015 Apr; 47(4):813-23. PubMed ID: 25557051
[TBL] [Abstract][Full Text] [Related]
34. 188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment.
Altai M; Wållberg H; Honarvar H; Strand J; Orlova A; Varasteh Z; Sandström M; Löfblom J; Larsson E; Strand SE; Lubberink M; Ståhl S; Tolmachev V
J Nucl Med; 2014 Nov; 55(11):1842-8. PubMed ID: 25278516
[TBL] [Abstract][Full Text] [Related]
35. Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41.
Welling MM; Visentin R; Feitsma HI; Lupetti A; Pauwels EK; Nibbering PH
Nucl Med Biol; 2004 May; 31(4):503-9. PubMed ID: 15093821
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC).
Maresca KP; Hillier SM; Femia FJ; Zimmerman CN; Levadala MK; Banerjee SR; Hicks J; Sundararajan C; Valliant J; Zubieta J; Eckelman WC; Joyal JL; Babich JW
Bioconjug Chem; 2009 Aug; 20(8):1625-33. PubMed ID: 19572702
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
Baishya R; Nayak DK; Chatterjee N; Halder KK; Karmakar S; Debnath MC
Chem Biol Drug Des; 2014 Jan; 83(1):58-70. PubMed ID: 23679852
[TBL] [Abstract][Full Text] [Related]
38. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
39. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.
Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R
Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540
[TBL] [Abstract][Full Text] [Related]
40. Radiopharmacological evaluation of (18)F-labeled phosphatidylserine-binding peptides for molecular imaging of apoptosis.
Wuest M; Perreault A; Kapty J; Richter S; Foerster C; Bergman C; Way J; Mercer J; Wuest F
Nucl Med Biol; 2015 Nov; 42(11):864-74. PubMed ID: 26205076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]